Results 21 to 30 of about 9,624 (181)

LINC01232 serves as a novel biomarker and promotes tumour progression by sponging miR-204-5p and upregulating RAB22A in clear cell renal cell carcinoma

Annals of Medicine, 2021
Background Long non-coding RNAs (lncRNAs) are involved in the progression of various cancers, including clear cell renal cell carcinoma (ccRCC). This study aimed to investigate the expression and prognostic value of long intergenic non-protein coding RNA
Qingling Liu, Chengbin Lei
doaj   +1 more source

Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients

Journal of Multidisciplinary Healthcare, 2023
Yuhao Zeng,1,* Sha Zhu,1,* Zilin Wang,1 Junru Chen,1 Jindong Dai,1 Zhenhua Liu,1 Guangxi Sun,1 Jiayu Liang,1 Xingming Zhang,1 Zhipeng Wang,1 Jinge Zhao,1 Yuchao Ni,1 Jiyu Yang,1 Minghao Wang,1 Qiang Wei,1 Xiang Li,1 Ni Chen,2 Zhiping Li,3 Xin ...
Zeng Y, Zhu S, Wang Z, Chen J, Dai J, Liu Z, Sun G, Liang J, Zhang X, Wang Z, Zhao J, Ni Y, Yang J, Wang M, Wei Q, Li X, Chen N, Li Z, Wang X, Shen Y, Yao J, Huang R, Liu J, Cai D, Zeng H, Shen P   +25 more
doaj  

Cellular milieu in clear cell renal cell carcinoma

Frontiers in Oncology, 2022
Clear cell renal cell carcinoma (ccRCC) is globally the most prevalent renal cancer. The cells of origin in ccRCC have been identified as proximal tubular epithelial cells (PTEC); however, the transcriptomic pathways resulting in the transition from ...
Arti M. Raghubar, Arti M. Raghubar, Arti M. Raghubar, Arti M. Raghubar, Arti M. Raghubar, Matthew J. Roberts, Matthew J. Roberts, Matthew J. Roberts, Matthew J. Roberts, Simon Wood, Simon Wood, Helen G. Healy, Helen G. Healy, Helen G. Healy, Andrew J. Kassianos, Andrew J. Kassianos, Andrew J. Kassianos, Andrew J. Mallett, Andrew J. Mallett, Andrew J. Mallett, Andrew J. Mallett   +20 more
doaj   +1 more source

Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma

Journal of Inflammation Research, 2022
Yiguan Qian,* Yang Li,* Ke Chen,* Ning Liu, Xi Hong, Di Wu, Zheng Xu, Liuhua Zhou, Luwei Xu, Ruipeng Jia, Yu-Zheng Ge Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China&ast ...
Qian Y, Li Y, Chen K, Liu N, Hong X, Wu D, Xu Z, Zhou L, Xu L, Jia R, Ge YZ   +10 more
doaj  

Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets

, 2023
Lipid droplet formation is a defining histological feature in clear-cell renal cell carcinoma (ccRCC) but the underlying mechanisms and importance of this biological behaviour have remained enigmatic.
Welford, Scott M, Merchan, Jaime R, Hougen, Helen Y, Gonzalgo, Mark L, Tan, Sze Kiat   +4 more
core   +1 more source

PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability [PDF]

JCI Insight, 2021
Proline rich 11 (PRR11), a novel tumor-related gene, has been identified in different tumors. However, the relevant biological functions of PRR11 in human clear cell renal cell carcinoma (ccRCC) have not been studied. In this study, we first identified PRR11 as a biomarker of ccRCC and predictor of poor prognosis by bioinformatics.
Siming Chen, Zhiwen He, Tianchen Peng, Fenfang Zhou, Gang Wang, Kaiyu Qian, Lingao Ju, Yu Xiao, Xinghuan Wang   +8 more
openaire   +3 more sources

Prognostic role of the beta-2 adrenergic receptor in clear cell renal cell carcinoma

Animal Cells and Systems, 2019
The beta-2 adrenergic receptor (ADRB2) regulates the proliferation, apoptosis, angiogenesis, migration, and metastasis of cancer cells. However, its function in the progression of clear cell renal cell carcinoma (ccRCC) is unknown.
Mihyang Ha, Dong Woo Kim, Jayoung Kim, Chae Mi Hong, Su Min Park, In Ae Woo, Min Yong Kim, Hyunjun Koo, Jin Namkoong, Jaehyun Kim, Myoung-Eun Han, Parkyong Song, Jin Hur, Chi-Dug Kang, Yun Hak Kim, Dongjun Lee, Sae-Ock Oh   +16 more
doaj   +1 more source

Single-cell RNA-sequencing analysis reveals MYH9 promotes renal cell carcinoma development and sunitinib resistance via AKT signaling pathway

Cell Death Discovery, 2022
Clear cell renal cell carcinoma (ccRCC) is a serious threat to human health worldwide, while its heterogeneity limits therapeutic success and leads to poor survival outcomes.
Zhipeng Xu, Min Liu, Jin Wang, Kai Liu, Liuyu Xu, Demin Fan, Hui Zhang, Wenxin Hu, Dan Wei, Jianning Wang   +9 more
doaj   +1 more source

SAM between two ccRCC identified groups.

, 2020
SAM between two ccRCC identified groups.
Guillermo de Velasco (3457934), Enrique Espinosa (175501), Angelo Gámez-Pozo (175480), Andrea Zapater-Moros (6896114), Elena López-Camacho (8506821), Carlos A. Farfán Tello (8506818), Natalia Miranda (8506815), Lucía Trilla-Fuertes (4096813), Álvaro Pinto (6896129), Daniel Castellano (514160), Rocío López-Vacas (175488), Guillermo Prado-Vázquez (4096810), Juan Ángel Fresno Vara (8506824), Felipe Villacampa (3559574)   +13 more
core   +1 more source

Screening and identification of prognostic genes associated with eosinophilic features of clear cell renal cell carcinoma

Heliyon, 2023
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cell carcinoma, which is characterized by transparent cytoplasm. However, some ccRCC also show eosinophilic cytoplasm, and the molecular difference between eosinophilic and clear
Tuanjie Guo, Liren Jiang, Tao Wang, Jian Zhang, Yang Liu, Xuan Wang, Ning Zhang, Siteng Chen, Xiang Wang   +8 more
doaj   +1 more source